Berkshire Hathaway sells entire UnitedHealth stake under new CEO
Berkshire Hathaway exited its entire position in UnitedHealth Group during the first quarter of 2025, part of a broader portfolio reshuffle following Greg Abel's succession of Warren Buffett as CEO. The sale came as the health insurer was rebounding from previous headwinds. The move signals a strategic shift under Abel's leadership, who has been gradually taking over investment decisions. UnitedHealth shares have recovered after a challenging 2024, but Berkshire's complete divestment suggests a lack of confidence in the sector or a reallocation to other opportunities. The exact timing and rationale remain undisclosed, but the transaction aligns with Abel's known preference for more concentrated holdings in certain industries.
Key facts
- Berkshire Hathaway sold its entire stake in UnitedHealth Group.
- The sale occurred in the first quarter of 2025.
- Greg Abel succeeded Warren Buffett as CEO.
- The divestment was part of a broader portfolio reshuffle.
- UnitedHealth was rebounding from previous challenges.
- Abel has been taking over investment decisions.
- The exact rationale for the sale was not disclosed.
- The move indicates a strategic shift under new leadership.
Entities
Institutions
- Berkshire Hathaway
- UnitedHealth Group
Sources
- Quartz —